J.P. Morgan Lifts Natera, Inc. (NTRA) Target on Signatera Momentum [Yahoo! Finance]
JP Morgan Chase & Co. (JPM)
Last jp morgan chase & co. earnings: 4/14 06:43 am
Check Earnings Report
US:NYSE Investor Relations:
jpmorganchase.com/corporate/investor-relations/investor-relations.htm
Company Research
Source: Yahoo! Finance
TheFly reported on December 15 that J.P. Morgan raised its price target on NTRA from $250 to $260 while maintaining an Overweight rating, reflecting confidence in the company's growth prospects driven by strong operational momentum and rapid adoption of its Signatera molecular residual disease (MRD) test. Around the same time, Barclays maintained its Overweight rating with a $270 price target, and Jefferies raised its target to $275, underscoring broad analyst optimism about Signatera's role in oncology diagnostics and recurring revenue potential. The bullish sentiment is supported by recent clinical and scientific validation of Signatera. On December 18, Natera, Inc. (NASDAQ:NTRA) announced the publication of Phase III CALGB (Alliance)/SWOG 80702 data in JAMA Oncology showing that Signatera-positive colorectal cancer patients had significantly improved outcomes when treated with celecoxib plus chemotherapy versus chemotherapy alone, reinforcing the test's prognostic utility in s
Show less
Read more
Impact Snapshot
Event Time:
JPM
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
JPM alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
JPM alerts
High impacting JP Morgan Chase & Co. news events
Weekly update
A roundup of the hottest topics
JPM
News
- JEPI Does The Job, But I Like GPIQ Better [Seeking Alpha]Seeking Alpha
- AI is reshaping banking—but not causing a jobs wipeout [Fortune]Fortune
- Major central banks deliver biggest easing push in over a decade in 2025 [Globe and Mail, The (Toronto, Canada)]Globe and Mail, The
- 7 Rising Stars who took Wall Street by storm after starting their careers in sports, science, and engineering [Business Insider]Business Insider
- Analysts Lower Price Targets on Wendy's (WEN) [Yahoo! Finance]Yahoo! Finance
JPM
Earnings
- 10/14/25 - Beat
JPM
Sec Filings
- 12/23/25 - Form 424B2
- 12/23/25 - Form 424B2
- 12/23/25 - Form 424B2
- JPM's page on the SEC website